This book considers the key sectors of China's health care system after its entrance into the WTO, including the pharmaceutical industry, health insurance services, and hospitals in terms of policies, legal framework and market potential. It offers a critical analysis of the impact of the WTO and globalization on China's health care.

Auteur
MEI LING WANG is Associate Professor of Social Sciences and Health Policy at the University of the Sciences in Philidelphia, USA. She studied at the Harvard School of Public Health and has devoted her career to writing on global issues.

SHUO ZHANG works for DSS VHA, in Texas, USA and has been at the frontline of China's health system.

XIAO-WAN WANG is Professor of Health Economics at the school of Public Health, Central South University, China. He has first hand experience of working in China's health system as an academic and policy analyst.

Contenu
Introduction; M.L.Wang WTO and China's Health Insurance Sector; S.Zhang & M.L.Wang Global Pharmaceutical Industry and China's Position; M.L.Wang WTO and the Present and Future of China's Pharmaceutical Industry; M.LWang WTO, Hospital Reform, and Health Service Provision in China; M.LWang & X.Wang WTO, Challenges and Opportunities to China's Health Care System; M.L Wang